FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199445929> ?p ?o ?g. }

• W3199445929 endingPage "3404" @default.
• W3199445929 startingPage "3392" @default.
• W3199445929 abstract "Abstract In the wake of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, an increasing number of patients with neurological disorders, including Guillain-Barré syndrome (GBS), have been reported following this infection. It remains unclear, however, if these cases are coincidental or not, as most publications were case reports or small regional retrospective cohort studies. The International GBS Outcome Study is an ongoing prospective observational cohort study enrolling patients with GBS within 2 weeks from onset of weakness. Data from patients included in this study, between 30 January 2020 and 30 May 2020, were used to investigate clinical and laboratory signs of a preceding or concurrent SARS-CoV-2 infection and to describe the associated clinical phenotype and disease course. Patients were classified according to the SARS-CoV-2 case definitions of the European Centre for Disease Prevention and Control and laboratory recommendations of the World Health Organization. Forty-nine patients with GBS were included, of whom eight (16%) had a confirmed and three (6%) a probable SARS-CoV-2 infection. Nine of these 11 patients had no serological evidence of other recent preceding infections associated with GBS, whereas two had serological evidence of a recent Campylobacter jejuni infection. Patients with a confirmed or probable SARS-CoV-2 infection frequently had a sensorimotor variant 8/11 (73%) and facial palsy 7/11 (64%). The eight patients who underwent electrophysiological examination all had a demyelinating subtype, which was more prevalent than the other patients included in the same time window [14/30 (47%), P = 0.012] as well as historical region and age-matched control subjects included in the International GBS Outcome Study before the pandemic [23/44 (52%), P = 0.016]. The median time from the onset of infection to neurological symptoms was 16 days (interquartile range 12–22). Patients with SARS-CoV-2 infection shared uniform neurological features, similar to those previously described in other post-viral GBS patients. The frequency (22%) of a preceding SARS-CoV-2 infection in our study population was higher than estimates of the contemporaneous background prevalence of SARS-CoV-2, which may be a result of recruitment bias during the pandemic, but could also indicate that GBS may rarely follow a recent SARS-CoV-2 infection. Consistent with previous studies, we found no increase in patient recruitment during the pandemic for our ongoing International GBS Outcome Study compared to previous years, making a strong relationship of GBS with SARS-CoV-2 unlikely. A case-control study is required to determine if there is a causative link or not." @default.
• W3199445929 created "2021-09-27" @default.
• W3199445929 creator A5000168044 @default.
• W3199445929 creator A5000213801 @default.
• W3199445929 creator A5001128906 @default.
• W3199445929 creator A5002405475 @default.
• W3199445929 creator A5004383772 @default.
• W3199445929 creator A5004563007 @default.
• W3199445929 creator A5006476216 @default.
• W3199445929 creator A5008399113 @default.
• W3199445929 creator A5008746846 @default.
• W3199445929 creator A5009208394 @default.
• W3199445929 creator A5009518785 @default.
• W3199445929 creator A5009588500 @default.
• W3199445929 creator A5010308866 @default.
• W3199445929 creator A5011065516 @default.
• W3199445929 creator A5011391490 @default.
• W3199445929 creator A5013265464 @default.
• W3199445929 creator A5014001531 @default.
• W3199445929 creator A5014114939 @default.
• W3199445929 creator A5014400249 @default.
• W3199445929 creator A5014957033 @default.
• W3199445929 creator A5015511187 @default.
• W3199445929 creator A5015772382 @default.
• W3199445929 creator A5016133672 @default.
• W3199445929 creator A5016623691 @default.
• W3199445929 creator A5017184747 @default.
• W3199445929 creator A5017810039 @default.
• W3199445929 creator A5017977989 @default.
• W3199445929 creator A5018546046 @default.
• W3199445929 creator A5019073401 @default.
• W3199445929 creator A5020089799 @default.
• W3199445929 creator A5020120126 @default.
• W3199445929 creator A5020879974 @default.
• W3199445929 creator A5021523757 @default.
• W3199445929 creator A5021855396 @default.
• W3199445929 creator A5021996805 @default.
• W3199445929 creator A5022452075 @default.
• W3199445929 creator A5023627853 @default.
• W3199445929 creator A5025254121 @default.
• W3199445929 creator A5026264965 @default.
• W3199445929 creator A5027493269 @default.
• W3199445929 creator A5027891257 @default.
• W3199445929 creator A5028344035 @default.
• W3199445929 creator A5028997407 @default.
• W3199445929 creator A5029334021 @default.
• W3199445929 creator A5030631016 @default.
• W3199445929 creator A5031144599 @default.
• W3199445929 creator A5031463226 @default.
• W3199445929 creator A5031894298 @default.
• W3199445929 creator A5032088865 @default.
• W3199445929 creator A5032138041 @default.
• W3199445929 creator A5032437498 @default.
• W3199445929 creator A5032503170 @default.
• W3199445929 creator A5032510994 @default.
• W3199445929 creator A5032536875 @default.
• W3199445929 creator A5033508970 @default.
• W3199445929 creator A5033536991 @default.
• W3199445929 creator A5033776935 @default.
• W3199445929 creator A5034101766 @default.
• W3199445929 creator A5034115945 @default.
• W3199445929 creator A5034122771 @default.
• W3199445929 creator A5035236296 @default.
• W3199445929 creator A5035309917 @default.
• W3199445929 creator A5036040469 @default.
• W3199445929 creator A5036125773 @default.
• W3199445929 creator A5036371818 @default.
• W3199445929 creator A5036796689 @default.
• W3199445929 creator A5037368893 @default.
• W3199445929 creator A5038006814 @default.
• W3199445929 creator A5038382731 @default.
• W3199445929 creator A5038450159 @default.
• W3199445929 creator A5039237680 @default.
• W3199445929 creator A5039280109 @default.
• W3199445929 creator A5039717492 @default.
• W3199445929 creator A5039891659 @default.
• W3199445929 creator A5039905544 @default.
• W3199445929 creator A5039954115 @default.
• W3199445929 creator A5040065704 @default.
• W3199445929 creator A5041365089 @default.
• W3199445929 creator A5041504666 @default.
• W3199445929 creator A5041506199 @default.
• W3199445929 creator A5042265614 @default.
• W3199445929 creator A5042309583 @default.
• W3199445929 creator A5042413184 @default.
• W3199445929 creator A5042879776 @default.
• W3199445929 creator A5043026792 @default.
• W3199445929 creator A5043219314 @default.
• W3199445929 creator A5043409198 @default.
• W3199445929 creator A5044103504 @default.
• W3199445929 creator A5045131316 @default.
• W3199445929 creator A5045462913 @default.
• W3199445929 creator A5045699068 @default.
• W3199445929 creator A5045704441 @default.
• W3199445929 creator A5045821339 @default.
• W3199445929 creator A5046225491 @default.
• W3199445929 creator A5046476077 @default.
• W3199445929 creator A5046997820 @default.

• next